关键词: Argentina BCG Brazil Colombia Latin America Mexico NMIBC clinical trials patient advocacy public health urology

来  源:   DOI:10.3332/ecancer.2024.1711   PDF(Pubmed)

Abstract:
Non-muscle invasive bladder cancer (NMIBC) is characterised by high rates of recurrence and progression, requiring substantial healthcare resources. In Latin America, the incidence of NMIBC is set to increase due to an aging population and lifestyle changes. To better understand the current challenges for NMIBC treaters and patients, a mixed-methods approach was leveraged combining secondary research with qualitative interviews from healthcare providers in Brazil, Colombia, Mexico and Argentina. Our analysis found that significant challenges persist across the region, particularly due to Bacillus Calmette-Guérin shortages, inconsistent adherence to clinical guidelines and significant socioeconomic disparities for patients accessing healthcare services. Addressing these challenges requires improved patient advocacy, strategic use of clinical trials and better resource distribution to enhance NMIBC management across Latin America.
摘要:
非肌层浸润性膀胱癌(NMIBC)的特点是复发和进展率高,需要大量的医疗资源。在拉丁美洲,由于人口老龄化和生活方式的改变,NMIBC的发病率将会增加。为了更好地了解NMIBC治疗者和患者当前面临的挑战,采用混合方法方法,将二级研究与巴西医疗保健提供者的定性访谈相结合,哥伦比亚,墨西哥和阿根廷。我们的分析发现,整个地区仍然存在重大挑战,特别是由于卡介苗短缺,不一致的坚持临床指南和显著的社会经济差异患者获得医疗服务。应对这些挑战需要改善患者的宣传,战略使用临床试验和更好的资源分配,以加强整个拉丁美洲的NMIBC管理。
公众号